Kalaris Therapeutics (KLRS) Shares Outstanding (2019 - 2026)
Kalaris Therapeutics (KLRS) recorded Shares Outstanding of 23.8 million in Q2 2026, up 27.2% from 18.7 million a year earlier and up 0.3% from the prior quarter.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) Shares Outstanding (2019 - 2026) Analysis & Trends
For FY2025, Kalaris Therapeutics reported Shares Outstanding of 15.27 million, up 204.8% from FY2024.
- Annual Shares Outstanding has a five-year compound annual growth rate of -10.7% (FY2020 to FY2025).
- Across earlier years, Shares Outstanding came in at 5.01 million in FY2024 (-95.2%), 104.06 million in FY2023 (+35.7%), 76.65 million in FY2022 (+22.1%) and 62.78 million in FY2021 (+133.4%).
- The Q2 2026 figure is the highest quarterly Shares Outstanding since Q3 2024.
- On a year-over-year basis, Shares Outstanding has increased for three consecutive quarters, with growth averaging 44.9% over the last eight quarters.
- Peak year-over-year performance for Shares Outstanding in the last five years was growth of 485.3% in Q1 2026, against a decline of 96.5% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 23.72 million (Q1 2026), 15.27 million (Q4 2025) and 18.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 891.90 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.47 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.94 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.55 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 541.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.24 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.70 Bn |
| 10 | Kalaris Therapeutics | 44.52 Mn | -38.38 Mn | - | 23.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 23.80 Mn |
| Jun 30, 2026 | 23.80 Mn |
| Mar 31, 2026 | 23.72 Mn |
| Dec 31, 2025 | 15.27 Mn |
| Sep 30, 2025 | 18.70 Mn |
| Jun 30, 2025 | 18.70 Mn |
| Mar 31, 2025 | 4.05 Mn |
| Dec 31, 2024 | 5.01 Mn |
| Sep 30, 2024 | 115.40 Mn |
| Jun 30, 2024 | 115.13 Mn |
| Mar 31, 2024 | 114.69 Mn |
| Dec 31, 2023 | 104.06 Mn |
| Sep 30, 2023 | 113.89 Mn |
| Jun 30, 2023 | 94.63 Mn |
| Mar 31, 2023 | 93.30 Mn |
| Dec 31, 2022 | 76.65 Mn |
| Sep 30, 2022 | 84.95 Mn |
| Jun 30, 2022 | 64.47 Mn |
| Mar 31, 2022 | 63.99 Mn |
| Dec 31, 2021 | 62.78 Mn |
API Access
Kalaris Therapeutics Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();